Koers MiCo BioMed Co., Ltd.
Aandelen
A214610
KR7214610008
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.442 KRW | +0,14% | +1,12% | -22,14% |
1 week | +1,12% | ||
1 maand | -16,89% |
Omzet 2022 | 16,11 mld. 11,89 mln. 11,05 mln. | Omzet 2023 | 5,37 mld. 3,96 mln. 3,68 mln. | Marktkapitalisatie | 80,68 mld. 59,54 mln. 55,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -38,89 mld. -28,7 mln. -26,68 mln. | Nettowinst (verlies) 2023 | -25,77 mld. -19,02 mln. -17,68 mln. | EV/omzet 2022 | 6,03 x |
Nettoschuld 2022 | 9,29 mld. 6,85 mln. 6,37 mln. | Nettoliquiditeiten 2023 | 8,98 mld. 6,63 mln. 6,16 mln. | EV/omzet 2023 | 13,4 x |
K/w-verhouding 2022 |
-2,26
x | K/w-verhouding 2023 |
-1,78
x | Werknemers | 88 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 87,65% |
1 dag | +0,14% | ||
1 week | +1,12% | ||
1 maand | -16,89% | ||
3 maanden | -18,85% | ||
6 maanden | -42,99% | ||
Lopend jaar | -22,14% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sung-Woo Kim
CEO | Chief Executive Officer | 66 | - |
Seong-Gyu Lee
DFI | Director of Finance/CFO | 59 | 31-08-17 |
Jin-Pyeong Kim
SAM | Sales & Marketing | 51 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Seon-Kyu Jeon
CHM | Chairman | 66 | 31-08-17 |
Sung-Woo Kim
CEO | Chief Executive Officer | 66 | - |
Seong-Gyu Lee
DFI | Director of Finance/CFO | 59 | 31-08-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
03-05-24 | 1.442 | +0,14% | 52 286 |
02-05-24 | 1.440 | -0,14% | 63 670 |
30-04-24 | 1.442 | +2,27% | 83 995 |
29-04-24 | 1.410 | -1,12% | 113 499 |
26-04-24 | 1.426 | -2,66% | 252 582 |
slotkoers Korea S.E., 03 mei 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-22,14% | 46,37 mln. | |
-14,68% | 18,88 mld. | |
-42,33% | 2,84 mld. | |
+17,00% | 1,85 mld. | |
-0,51% | 1,66 mld. | |
+27,15% | 1,26 mld. | |
-13,90% | 989 mln. | |
-21,76% | 896 mln. | |
-2,72% | 757 mln. | |
-23,95% | 637 mln. |